Abstract
Cyclooxygenase (COX) has two isoforms. Generally, COX 1 is constitutively expressed in most tissues, where it maintains physiological processes1; inducible COX 2 is considered a pro-inflammatory enzyme and a chief target for the treatment of inflammatory diseases2. Here we present evidence that COX 2 may have anti-inflammatory properties. In carrageenin-induced pleurisy in rats, the predominant cells at 2 hours are polymorphonuclear leucocytes, whereas mononuclear cells dominate from 24 hours until resolution at 48 hours3. In this model, COX 2 protein expression peaked initially at 2 hours, associated with maximal prostaglandin E2 synthesis. However, at 48 hours there was a second increase in COX 2 expression, 350% greater than that at 2 hours. Paradoxically, this coincided with inflammatory resolution and was associated with minimal prostaglandin E2 synthesis. In contrast, levels of prostaglandin D2, and 15deoxyΔ12,13,14prostaglandin J2 were high at 2 hours, decreased as inflammation increased, but were increased again at 48 hours. The selective COX 2 inhibitor NS-398 and the dual COX 1/COX 2 inhibitor indomethacin inhibited inflammation at 2 hours but significantly exacerbated inflammation at 48 hours. This exacerbation was associated with reduced exudate prostaglandin D2 and 15deoxyΔ12,13,14prostaglandin J2 concentrations, and was reversed by replacement of these prostaglandins. Thus, COX 2 may be pro-inflammatory during the early phase of a carrageenin-induced pleurisy, dominated by polymorphonuclear leucocytes, but may aid resolution at the later, mononuclear cell-dominated phase by generating an alternative set of anti-inflammatory prostaglandins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
DeWitt, D.L. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta 1083, 121–134 (1991).
Vane, J.R. Towards a better aspirin. Nature 367, 215 –216 (1994).
Tomlinson, A. et al. Cyclooxygenase and nitric oxide synthase isoforms in rat carrageenin- induced pleurisy. Br. J. Pharmacol. 113 , 693–698 (1994).
Willis, D., Moore, A.R., Frederick, R., Willoughby, D.A. & Heme Oxygenase: A novel target for the modulation of the inflammatory response. Nature Med. 2, 87 –90 (1996).
Futaki, N. et al. NS-398, a new antiinflammatory agent, selectively inhibits prsotaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47, 55– 59 (1994).
Mitchell, J.A., Akarasereenont, P., Thiemermann, C., Flowers, R.J. & Vane, J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA 90, 11693– 11697 (1993).
Masferrer, J.L. et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91, 3228–32 ( 1994).
Masso, J.M., Villar, A.M., Conde, J.R. & Martorell, J. Effects of fepradinol on rat acute models of vascular permeability and leucocyte migration. Agents Actions 42, 118– 22 (1994).
Williams, K.I. & Higgs, G.A. Eicosanoids and inflammation. J. Pathol. 156, 101–110 (1988).
Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J. & Glass, C.K. The peroxisome proliferator- activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79–82 (1998).
Spencer, A.G., Woods, J.W. Arakawa, J.W., Singer, I.I. & Smith, W.L. Subcellular localisation of prostaglandin endoperoxide H synthase-1 and -2 by immunoelectron microscopy. J. Biol. Chem. 273, 9886–9893 (1998).
Ujihara, M. et al. Prostaglandin D2 formation and characterisation of its synthetases in various tissues of adult rats. Arch. Biochem. Biophys. 260, 521–531 ( 1988).
Fournier, T., Fadok, V., Henson, P.M. Tumor necrosis factor-α inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. J. Biol. Chem. 272, 31065–31072 (1997).
Mizuno, H. et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112, 387–397 (1997).
Schmassmann, A. et al. Effects of inhibition of prostaglandin endoperoxide synthase 2 in gastric intestinal models in rats. Br. J. Pharmacol. 123, 795–805 (1998).
Shigeta J., Takashi, S., Okabe, S. Role of cyclooxygenase 2 in the healing of gastric ulcers in rats. J. Pharmacol. Exp. Therap. 286, 1383– 1390 (1998).
Medical Research Council and Nuffield Foundation Joint Committee. Ann. Rheumatic Dis. 18, 173– 188 (1959).
Gilroy, D., Tomlinson, A., Greenslade, K., Seed, M.P. & Willoughby, D.A. The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of mycobacterium tuberculosis-induced monoarticular arthritis in the rat. Inflammation 22, 509–519 ( 1998).
Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–54 ( 1976).
Acknowledgements
The authors acknowledge the support of the following organizations: D.W.G., The Hyal Research Foundation, Canada; P.R.C.-N., The Joint Research Board of the Special Trustees of St. Bartholomew's Hosptial, London, UK and the Arthritis Research Campaign, UK; D.W., Oliver Bird Fund, Nuffield Foundation, UK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gilroy, D., Colville-Nash, P., Willis, D. et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5, 698–701 (1999). https://doi.org/10.1038/9550
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/9550
This article is cited by
-
Peroxisome proliferator activated receptor-gamma (PPAR-γ) ligand, pioglitazone, increases analgesic and anti-inflammatory effects of naproxen
Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
-
Pro- and anti-inflammatory bioactive lipids imbalance contributes to the pathobiology of autoimmune diseases
European Journal of Clinical Nutrition (2023)
-
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
Nature Reviews Cardiology (2023)
-
Resolving inflammation
Nature Reviews Immunology (2021)
-
Postpartum meloxicam administration alters plasma haptoglobin, polyunsaturated fatty acid, and oxylipid concentrations in postpartum ewes
Journal of Animal Science and Biotechnology (2020)